FLT3 and acute myeloid leukemia: As mentioned above, in the early 2000s, it became evident that most such patients with FLT3 mutant AML relapsed early, with disease characterized by high variant allele frequency (VAF), dependence on FLT3 signaling, and resistance to chemotherapy.